Flemming Steen Jørgensen

Citeret af

	Alle	Siden 2018
Henvisninger	3675	950
h-index	33	18
i10-indeks	73	34

200

100

150

198419851986198719881989199019911992199319941995199619971998199920002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202315 6 14 6 11 16 29 34 34 31 38 37 30 39 38 34 39 47 51 69 83 93 117 130 128 148 162 177 176 164 138 168 190 172 183 177 145 163 194 87

Offentlig adgang

Se alle

12 artikler

3 artikler

tilgængelige

ikke tilgængelige

Baseret på krav i forbindelse med finansiering

Medforfattere

Lars OlsenDepartment of Drug Design and Pharmacology, University of CopenhagenVerificeret mail på novozymes.com
Vasanthanathan PoongavanamUppsala UniversityVerificeret mail på kemi.uu.se
Carsten Uhd NielsenDepartment of Physics, Chemistry and Pharmacy, Faculty of Sciences, University of Southern DenmarkVerificeret mail på sdu.dk
Søren BrunakProfessor of Disease Systems Biology, University of CopenhagenVerificeret mail på cpr.ku.dk
Birger BrodinProfessor, CNS drug delivery, University of CopenhagenVerificeret mail på sund.ku.dk
Marco van de WeertAssociate Professor in Biologics formulation, University of CopenhagenVerificeret mail på sund.ku.dk
Lars HemmingsenDepartment of Chemistry, University of CopenhagenVerificeret mail på chem.ku.dk
R. Stan BrownProfessor of Chemistry, Queen's UniversityVerificeret mail på chem.queensu.ca
Michael GajhedeProfessor i proteinkrystallografi, Københavns UniversitetVerificeret mail på sund.ku.dk
Tudor OpreaEmeritus Professor of Medicine, UNM SOMVerificeret mail på salud.unm.edu
Qiyuan LiSchool of Medicine, Xiamen UniversityVerificeret mail på xmu.edu.cn
Anders Skov KristensenUniversity of CopenhagenVerificeret mail på sund.ku.dk
Kasper B. HansenAssociate Professor, University of MontanaVerificeret mail på mso.umt.edu
Henrik LeffersSenior Scientist, University of Copenhagen, Denmark. henrik@leffers.proVerificeret mail på leffers.pro
Patrik RydbergAssociate Director, Computational Chemmistry, Optibrium Ltd.Verificeret mail på optibrium.com
Jukka Rantanen, professor PhDUniversity of CopenhagenVerificeret mail på sund.ku.dk
Hans Bräuner-OsborneProfessor of Molecular Pharmacology, University of CopenhagenVerificeret mail på sund.ku.dk
Vignir IsbergSenior Department Manager, NovozymesVerificeret mail på vignir.org
David N. CooperProfessor of Human Molecular Genetics, Cardiff University, UKVerificeret mail på cardiff.ac.uk
Peter BrossResearch Unit for Molecular Medicine, Aarhus University HospitalVerificeret mail på clin.au.dk

Følg

Flemming Steen Jørgensen

Professor, Department of Drug Design and Pharmacology, University of Copenhagen

Verificeret mail på sund.ku.dk

Molecular modelling computational chemistry structure-activity relationship


Titel Sortér efter henvisninger Sortér efter årstal Sortér efter titel	Citeret af Citeret af	År
Study on the binding of Thioflavin T to β-sheet-rich and non-β-sheet cavities M Groenning, L Olsen, M van de Weert, JM Flink, S Frokjaer, ... Journal of structural biology 158 (3), 358-369, 2007	287	2007
Prediction methods and databases within chemoinformatics: emphasis on drugs and drug candidates SÓ Jónsdóttir, FS Jørgensen, S Brunak Bioinformatics 21 (10), 2145-2160, 2005	141	2005
A new concept for multidimensional selection of ligand conformations (MultiSelect) and multidimensional scoring (MultiScore) of protein− ligand binding affinities GE Terp, BN Johansen, IT Christensen, FS Jørgensen Journal of medicinal chemistry 44 (14), 2333-2343, 2001	138	2001
Evaluation and comparison of 3D-QSAR CoMSIA models for CDK1, CDK5, and GSK-3 inhibition by paullones C Kunick, K Lauenroth, K Wieking, X Xie, C Schultz, R Gussio, ... Journal of Medicinal Chemistry 47 (1), 22-36, 2004	137	2004
GABAA receptor agonists, partial agonists, and antagonists. Design and therapeutic prospects P Krogsgaard-Larsen, B Frølund, FS Joergensen, A Schousboe Journal of medicinal chemistry 37 (16), 2489-2505, 1994	129	1994
Classification of cytochrome P450 1A2 inhibitors and noninhibitors by machine learning techniques P Vasanthanathan, O Taboureau, C Oostenbrink, NPE Vermeulen, ... Drug Metabolism and Disposition 37 (3), 658-664, 2009	115	2009
hERG classification model based on a combination of support vector machine method and GRIND descriptors Q Li, FS Jørgensen, T Oprea, S Brunak, O Taboureau Molecular pharmaceutics 5 (1), 117-127, 2008	110	2008
Mutational mapping and modeling of the binding site for (S)-citalopram in the human serotonin transporter J Andersen, L Olsen, KB Hansen, O Taboureau, FS Jørgensen, ... Journal of Biological Chemistry 285 (3), 2051-2063, 2010	108	2010
Structural differences of matrix metalloproteinases with potential implications for inhibitor selectivity examined by the GRID/CPCA approach GE Terp, G Cruciani, IT Christensen, FS Jørgensen Journal of medicinal chemistry 45 (13), 2675-2684, 2002	104	2002
Prediction of cytochrome P450 mediated metabolism L Olsen, C Oostenbrink, FS Jørgensen Advanced drug delivery reviews 86, 61-71, 2015	98	2015
Identification of a gene on chromosome 12q22 uniquely overexpressed in chronic lymphocytic leukemia AM Buhl, J Jurlander, FS Jørgensen, AM Ottesen, JB Cowland, ... Blood 107 (7), 2904-2911, 2006	95	2006
Prediction of pH-dependent aqueous solubility of druglike molecules NT Hansen, I Kouskoumvekaki, FS Jørgensen, S Brunak, SO Jonsdottir Journal of chemical information and modeling 46 (6), 2601-2609, 2006	92	2006
Virtual screening and prediction of site of metabolism for cytochrome P450 1A2 ligands P Vasanthanathan, J Hritz, O Taboureau, L Olsen, F Steen Jørgensen, ... Journal of chemical information and modeling 49 (1), 43-52, 2009	84	2009
Recent advances in GABA agonists, antagonists and uptake inhibitors: structure–activity relationships and therapeutic potential P KROGSGAARD-LARSEN, H HJEDS, E FALCH, FS JØRGENSEN, ... Advances in drug research 17, 381-456, 1988	80	1988
New leads of metallo-β-lactamase inhibitors from structure-based pharmacophore design L Olsen, S Jost, HW Adolph, I Pettersson, L Hemmingsen, FS Jørgensen Bioorganic & medicinal chemistry 14 (8), 2627-2635, 2006	68	2006
Solvent diversity in polymorph screening M Allesø, F Van Den Berg, C Cornett, FS Jørgensen, B Halling-Sørensen, ... Journal of pharmaceutical sciences 97 (6), 2145-2159, 2008	64	2008
Towards an understanding of drug resistance in malaria: three-dimensional structure of Plasmodium falciparum dihydrofolate reductase by homology building T Lemcke, IT Christensen, FS Jørgensen Bioorganic & medicinal chemistry 7 (6), 1003-1011, 1999	62	1999
Cyclynes. Part 5. Pericyclynes:" exploded cycloalkanes" with unusual orbital interactions and conformational properties. MM2 and STO-3G calculations, x-ray crystal structures … KN Houk, LT Scott, NG Rondan, DC Spellmeyer, G Reinhardt, JL Hyun, ... Journal of the American Chemical Society 107 (23), 6556-6562, 1985	61	1985
Homology modelling of the GABA transporter and analysis of tiagabine binding S Skovstrup, O Taboureau, H Bräuner‐Osborne, FS Jørgensen ChemMedChem 5 (7), 986-1000, 2010	59	2010
Primary structure and conformational analysis of peptide methionine—tyrosine, a peptide related to neuropeptide Y and peptide YY isolated from lamprey intestine JM CONLON, B BJØRNHOLM, FS JØRGENSEN, JH YOUSON, ... European journal of biochemistry 199 (2), 293-298, 1991	59	1991

Systemet kan ikke foretage handlingen nu. Prøv igen senere.

Artikler 1–20

Henvisninger pr. år

Dublerede henvisninger

Flettede henvisninger

Tilføj medforfattereMedforfattere

Følg

Citeret af

Medforfattere